Santini Gino
- SEC CIK
- 0001276038
No open-market purchases or sales filed in the past year.
Current role at each company
- COLL Collegium Pharmaceutical, IncDirectoras of Jun 10, 2026
- CMPS COMPASS Pathways plcDirectoras of May 29, 2026
- ICPT Intercept Pharmaceuticals, Inc.Directoras of Nov 13, 2023
- HZNP Horizon Therapeutics Public Ltd CoDirectoras of Oct 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Santini Gino as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
COLL Collegium Pharmaceutical, Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 (view filing) | Aug 15 | 4 days | Santini GinoDirector | SSale | −5.41K | $37.19 | −$201.0K | −5.4%95.0K after |